Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 07, 2015 1:53 PM ET

Life Sciences Tools and Services

Company Overview of nanoMR Inc.

Company Overview

nanoMR Inc., a life sciences company, develops Pathogen Capture System for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower for the blood culture market. Its system recovers microbial cells directly from blood drawn into a standard Green-Topped Vacutainer tube and delivers purified microbial DNA. The company was founded in 2006 and is based in Albuquerque, New Mexico. As of January 15, 2015, nanoMR Inc. operates as a subsidiary of DNA Electronics Limited.

5741 Midway Park Boulevard

Albuquerque, NM 87109

United States

Founded in 2006





Key Executives for nanoMR Inc.

Chief Executive Officer, President and Director
Vice President of Product Development
Chief Scientific Officer
Age: 62
Compensation as of Fiscal Year 2015.

nanoMR Inc. Key Developments

Nanomr Inc. Wins $21.5 Million Biothreat Contract

The Biomedical Advanced Research and Development Authority wants to use Nano-MR Inc.'s technology to build an automated device that could detect biothreat agents such as anthrax in just a few hours. The research and development authority, which is part of the U.S. Department of Health and Human Services, awarded the Albuquque company a three-year contract with $5.9 million in federal funding in the first year. If NanoMR meets required milestones, the contract's value could grow to a total of $21.5 million. NanoMR's technology has demonstrated the ability to detect infections and identify the type of bacteria present in blood in two hours. That compares with the 24 to 27 hours that doctors must wait for labs to grow cultures. Once extracted, technicians can rapidly identify the bacteria present, allowing doctors to begin antibiotic therapies before an infection has entered the bloodstream, which is known as sepsis. Apart from developing a specific analysis for anthrax and other bioagents, the company will build its diagnostic technology into a fully automated system, Esch said. Its current system is managed manually by technicians.

Similar Private Companies By Industry

Company Name Region
PMRS, Inc. United States
INB: Hauser Pharmaceutical Services, Inc. United States
Research Essential Services, LLC United States
International HealthCare, LLC United States
Eventus Diagnostics, Inc. United States

Recent Private Companies Transactions

January 16, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact nanoMR Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at